ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1702

Identification of Multiple Genetic Susceptibility Loci in Takayasu’s Arteritis

Guher Saruhan-Direskeneli1, Travis Hughes2, Patrick S. Coit2, Joel M. Guthridge3, Judith A. James4, Peter A. Merkel of behalf of the Vasculitis Clinical Research Consortium5, Haner Direskeneli on behalf of the Turkish Takayasu Study Group6 and Amr H. Sawalha2, 1Department of Physiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Division of Rheumatology, University of Michigan, Ann Arbor, MI, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 6Department of Rheumatology, Marmara University, Faculty of Medicine, Istanbul, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: genetics, genomics, polymorphism, takayasu arteritis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Takayasu’s arteritis is a rare inflammatory disease of large arteries. The etiology of Takayasu’s arteritis remains poorly understood, but genetic contribution to the disease pathogenesis is supported by the confirmed genetic association with HLAB*52. Genomic studies in Takayasu’s arteritis have not been previously performed.

Methods: We genotyped ~200,000 genetic variants in two ethnically divergent Takayasu’s arteritis cohorts from Turkey (339 patients and 516 controls) and North America (112 patients and 599 controls) using a custom designed genotyping platform (Immunochip). Additional genetic variants and the classical HLA alleles were imputed and analyzed.

Results: We identified and confirmed two independent susceptibility loci within the HLA region (r2<0.2): HLA-B/MICA (rs12524487, OR= 3.29, P= 5.57X10-16), and HLADQB1/ HLA-DRB1 (rs113452171, OR= 2.34, P= 3.74X10-9, and rs189754752, OR=2.47, P= 4.22X10-9). In addition, we identified and confirmed a novel genetic association between Takayasu’s arteritis and the FCGR2A/FCGR3A locus on chromosome 1 (rs10919543, OR= 1.81, P= 5.89X10-12). The risk allele in this locus results in increased mRNA expression of FCGR2A. We also established the genetic association between IL12B and Takayasu’s arteritis (rs56167332, OR= 1.54, P= 2.18X10-8). An association with an additional locus on chromosome 21q22 downstream of PSMG1 did not pass the threshold for genome-wide significance and requires replication (P=4.39X10-7).

Conclusion: We established multiple genetic susceptibility loci for Takayasu’s arteritis with a genome-wide level of significance including two independent susceptibility loci in the HLA region, and disease susceptibility loci in FCGR2A/FCGR3A and IL12B.


Disclosure:

G. Saruhan-Direskeneli,
None;

T. Hughes,
None;

P. S. Coit,
None;

J. M. Guthridge,
None;

J. A. James,

Pfizer Inc,

2,

GSK,

5;

P. A. Merkel of behalf of the Vasculitis Clinical Research Consortium,
None;

H. Direskeneli on behalf of the Turkish Takayasu Study Group,
None;

A. H. Sawalha,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-multiple-genetic-susceptibility-loci-in-takayasus-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology